344 related articles for article (PubMed ID: 23423815)
21. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
22. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
25. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
26. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
Marcinek J; Plank L; Szépe P; Balhárek T
Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
28. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
[TBL] [Abstract][Full Text] [Related]
29. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
30. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U; Roos G; Bergh A; Botling J; Lönnerholm G; Porwit A; Heyman M; Forestier E
Leukemia; 2008 Mar; 22(3):504-10. PubMed ID: 18094715
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Verstovsek S; Giles FJ; O'Brien S; Faderl S; Kantarjian HM; Keating MJ; Albitar M
Leuk Res; 2004 Jul; 28(7):707-11. PubMed ID: 15158092
[TBL] [Abstract][Full Text] [Related]
33. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
[TBL] [Abstract][Full Text] [Related]
34. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
Delgado J; Pratt G; Phillips N; Briones J; Fegan C; Nomdedeu J; Pepper C; Aventin A; Ayats R; Brunet S; Martino R; Valcarcel D; Milligan D; Sierra J
Br J Haematol; 2009 Jun; 145(6):801-5. PubMed ID: 19388937
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
Delgado J; Espinet B; Oliveira AC; Abrisqueta P; de la Serna J; Collado R; Loscertales J; Lopez M; Hernandez-Rivas JA; Ferra C; Ramirez A; Roncero JM; Lopez C; Aventin A; Puiggros A; Abella E; Carbonell F; Costa D; Carrio A; Gonzalez M; ;
Br J Haematol; 2012 Apr; 157(1):67-74. PubMed ID: 22224845
[TBL] [Abstract][Full Text] [Related]
36. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
39. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
